Nalaganje...

Killing of Borrelia burgdorferi by Antibody Elicited by OspA Vaccine Is Inefficient in the Absence of Complement

A Lyme disease vaccine, based on the Borrelia burgdorferi lipoprotein OspA, has recently undergone phase III trials in humans. The results of one of these trials indicate that vaccine efficacy positively correlates with anti-OspA antibody titer. Spirochete killing within the tick vector midgut, upon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nowling, Jena M., Philipp, Mario T.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 1999
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC96334/
https://ncbi.nlm.nih.gov/pubmed/9864253
Oznake: Označite
Brez oznak, prvi označite!